Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Induction of Influenza (H5N8)...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine

Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine

Bibliographic Details
Main Authors: Rory D. de Vries, Heidi L.M. De Gruyter, Theo M. Bestebroer, Mark Pronk, Ron A.M. Fouchier, Albert D.M.E. Osterhaus, Gerd Sutter, Joost H.C.M. Kreijtz, Guus F. Rimmelzwaan
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2015-06-01
Series:Emerging Infectious Diseases
Subjects:
vaccine
avian influenza
MVA
clinical trial
antibodies
zoonoses
Online Access:https://wwwnc.cdc.gov/eid/article/21/6/15-0021_article
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://wwwnc.cdc.gov/eid/article/21/6/15-0021_article

Similar Items

  • Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection
    by: Mareike Kubinski, et al.
    Published: (2024-01-01)
  • A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
    by: Mareike Kubinski, et al.
    Published: (2023-04-01)
  • Diseño y construcción de vectores de transferencia para la obtención de virus vaccinia Ankara modificado (MVA) recombinantes Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)
    by: M. F. Ferrer, et al.
    Published: (2007-09-01)
  • Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
    by: Lidewij C. M. Wiersma, et al.
    Published: (2015-03-01)
  • Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
    by: Juan García-Arriaza, et al.
    Published: (2021-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs